101 related articles for article (PubMed ID: 9684577)
21. p53 mutations in benign breast tissue.
Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ
J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086
[TBL] [Abstract][Full Text] [Related]
22. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
23. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.
Kuroda N; Jin YL; Hamauzu T; Toi M; Miyazaki E; Hiroi M; Moriki T; Enzan H
Histol Histopathol; 2005 Jul; 20(3):707-12. PubMed ID: 15944918
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma.
Cho MH; Yoon JH; Jaegal YJ; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Woo Juhng S; Min KW
Breast; 2006 Jun; 15(3):390-8. PubMed ID: 16169726
[TBL] [Abstract][Full Text] [Related]
25. The neurofibromin 1 type I isoform predominance characterises female population affected by sporadic breast cancer: preliminary data.
Marrero D; Peralta R; Valdivia A; De la Mora A; Romero P; Parra M; Mendoza N; Mendoza M; Rodriguez D; Camacho E; Duarte A; Castelazo G; Vanegas E; Garcia I; Vargas C; Arenas D; Jimenez F; Salcedo M
J Clin Pathol; 2012 May; 65(5):419-23. PubMed ID: 22412049
[TBL] [Abstract][Full Text] [Related]
26. The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions.
Mustonen M; Raunio H; Pääkkö P; Soini Y
Histopathology; 1997 Oct; 31(4):347-54. PubMed ID: 9363451
[TBL] [Abstract][Full Text] [Related]
27. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.
Rosen PP; Lesser ML; Arroyo CD; Cranor M; Borgen P; Norton L
J Clin Oncol; 1995 Apr; 13(4):821-30. PubMed ID: 7707107
[TBL] [Abstract][Full Text] [Related]
28. Terminal uridine nick end labelling and mitosis in breast carcinoma. Correlation with tumor grade and p53 overexpression.
Dey P; Luthra UK; George SS; Haji BI; George J
Anal Quant Cytol Histol; 2001 Feb; 23(1):27-30. PubMed ID: 11233740
[TBL] [Abstract][Full Text] [Related]
29. Nucleolar organizer regions in human breast cancer.
Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
[TBL] [Abstract][Full Text] [Related]
30. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
31. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
32. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
33. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Facina G; Lopes-Costa PV; Dos Santos AR; De Vasconcelos-Valença RJ; Pinho-Sobral AL; Ferreira-Filho CP; Alencar AP; Gebrim LH; Da Silva BB
Diagn Cytopathol; 2010 Apr; 38(4):235-8. PubMed ID: 19790246
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical demonstration of histone H1(0) in human breast carcinoma.
Kostova NN; Srebreva LN; Milev AD; Bogdanova OG; Rundquist I; Lindner HH; Markov DV
Histochem Cell Biol; 2005 Nov; 124(5):435-43. PubMed ID: 16158288
[TBL] [Abstract][Full Text] [Related]
36. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
[TBL] [Abstract][Full Text] [Related]
37. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
38. [Abnormal expression of RSK-4 and its clinical significance in breast cancer].
Liu JL; Yang HW; Chen ZS; Jiang Y
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):452-6. PubMed ID: 21875487
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of proCOL11A1 as a stromal marker of breast cancer.
Fuentes-Martínez N; García-Pravia C; García-Ocaña M; Menéndez-Rodríguez P; Del Amo J; Suárez-Fernández L; Galván JA; De los Toyos JR; Barneo L
Histol Histopathol; 2015 Jan; 30(1):87-93. PubMed ID: 25005174
[TBL] [Abstract][Full Text] [Related]
40. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
